Related Experiment Videos
Flow cytometric studies of human osteosarcoma.
H J Mankin1, M C Gebhardt, D S Springfield
1Orthopaedic Research Laboratories, Massachusetts General Hospital, Boston 02114.
Clinical Orthopaedics and Related Research
|September 1, 1991
Summary
Flow cytometry analysis of DNA distribution in osteosarcoma patients shows potential for predicting metastasis and treatment effectiveness. This technique may improve prognosis assessment for bone tumors.
Area of Science:
- Oncology
- Biotechnology
- Genetics
Background:
- Flow cytometry is increasingly recognized for its potential in assessing neoplasm malignancy.
- Its application in predicting the biologic behavior of bone tumors is an area of active research.
Purpose of the Study:
- To investigate the utility of flow cytometry in analyzing DNA distribution in osteosarcoma.
- To correlate DNA content abnormalities with patient survival and treatment response.
Main Methods:
- Studied DNA distribution (diploidy, S-phase, tetraploidy, aneuploidy) using propidium iodide and a home-built flow cytometer in 95 osteosarcoma patients.
- Calculated mean DNA concentration to quantify abnormalities compared to normal patterns.
- Correlated flow cytometry data with disease-free survival, total survival, and treatment effects (pre- and post-chemotherapy).
Main Results:
- Demonstrated significant DNA content abnormalities in osteosarcoma compared to normal patterns.
- Identified weak correlations between specific DNA patterns and increased risk of metastasis and death.
- Observed that treatment effects could be assessed by evaluating pre- and post-chemotherapy DNA patterns.
Conclusions:
- Flow cytometry shows promise in assessing osteosarcoma prognosis and predicting treatment efficacy.
- Further technological advancements may enhance its value in clinical decision-making for bone tumors.
- DNA distribution analysis via flow cytometry can provide insights into tumor behavior and patient outcomes.